期刊文献+

孕烷X受体及组成性雄甾烷受体的研究新进展 被引量:14

Advances in the research of pregnane X receptor and constitutive androstane receptor
原文传递
导出
摘要 孕烷受体(pregnane X receptor,PXR)和组成性雄甾烷受体(constitutive androstane receptor,CAR)是核受体(nuclear receptor,NR)亚家族的重要成员;为配体活化的转录因子,能调控大量的靶基因。本文主要对其基本结构、机制及参与转录活化的辅助因子作简要介绍,重点讲述了它们在调节药物代谢与转运、糖异生及生酮作用、脂质代谢以及炎症反应等方面的意义。通过对PXR及CAR的研究,可以有效预测和防止药物相互作用;为寻找疾病治疗新靶标提供方向。 Nuclear receptors pregnane X receptor(PXR) and constitutive androstane receptor(CAR) are originally characterized as transcription factors regulating many target genes.Recent works have revealed that these nuclear receptors play critical roles in regulating genes that encode drug metabolism enzymes and modulating hepatic energy metabolism,such as down-regulating gluconeogenesis,fatty acid oxidation,and ketogenesis,as well as up-regulating lipogenesis.Studies on PXR and CAR have important implication on drug-drug interaction(DDI) and potential disease treatment targets.
出处 《药学学报》 CAS CSCD 北大核心 2011年第10期1173-1177,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81001685) 教育部博士点新教师基金资助项目(20100171120058)
关键词 组成性雄甾烷受体 孕烷受体 核受体 药物代谢酶 糖异生 脂质代谢 炎症反应 constitutive androstane receptor pregnane X receptor nuclear receptor drug metabolism enzyme gluconeogenesis lipid metabolism inflammation
  • 相关文献

参考文献1

二级参考文献19

  • 1Crewe HK, Notley LM, Wunsch RM, et al. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos, 2002,30:869~874.
  • 2Schmidt R, Baumann F, Knupfer H, et al. CYP3A4, CYP2C9 and CYP2B6 expression and isofamide turnover in breast cancer tissue microsomes. Br J Cancer, 2004, 90:911~916.
  • 3Ando Y, Fuse E, Figg WD. Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res, 2002,8:1964~1973.
  • 4Howells RE, Dhar KK, Hoban PR, et al. Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 overexpression, and outcome in epithelial ovarian cancer. Int J Gynecol Cancer, 2004, 14:242~250.
  • 5King CD, Riso GR, Green MD, et al. UDP-glucuronyltransferases. Curr Drug Metal, 2000,1:143~161.
  • 6Brockdorff BL, Skouv J, Reiter BE, et al. Increased expression of cytochrome P4501A1 and 1B1 genes in anti-oestrogen-resistant human breast cancer cell lines. Int J Cancer, 2000, 88:902~906.
  • 7Miyoshi Y, Ando A, Takamura Y, et al. Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissue. Int J Cancer, 2002,97:129~132.
  • 8Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene, 2003, 22:7369~7375.
  • 9Murray GI. The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol, 2000,192:419~426.
  • 10Suzuki T, Nisho K, Tanabe S. The MRP family and anticancer drug metabolism. Curr Drug Metab, 2001, 2:367~377.

共引文献2

同被引文献142

引证文献14

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部